IMIC(SZ:000516) Sou Hu Cai Jing·2026-01-14 16:35Core Viewpoint - International Medical (000516) has experienced a significant stock price increase, closing at 6.19 yuan on January 14, 2026, marking a 9.95% rise and achieving consecutive trading limits for two days [1]. Trading Information Summary - On January 14, 2026, the net outflow of main funds was 171 million yuan, while retail investors saw a net inflow of 143 million yuan [3][7]. - International Medical was listed on the "Dragon and Tiger List" due to a cumulative price deviation of over 20% in the last three trading days, marking its first appearance on the list in the past five trading days [4][7]. Company Announcement Summary - The controlling shareholder, Shaanxi Century Xinyuan Commercial Management Co., Ltd., pledged 75 million shares to Chang'an International Trust Co., Ltd. on January 13, 2026. This pledge accounts for 12.17% of its holdings and 3.35% of the company's total share capital. After this pledge, the total pledged shares by Century Xinyuan reached 82.07% of its holdings, with a combined pledge by Century Xinyuan and its concerted actions amounting to 24.61% of the company's total share capital. The company stated that the pledge risk is controllable and will not lead to a change in actual control [5]. - The company confirmed that from January 12 to January 14, 2026, its stock price experienced a cumulative deviation exceeding 20%, constituting abnormal trading fluctuations. The company has verified that there are no undisclosed significant matters, and its operational situation remains normal. The controlling shareholder and actual controller did not trade the company's stock during this period. The company is not involved in the research, production, or sales of brain-computer interface products, and related application revenue has a minimal impact on its performance [6][7].